STOCK OPTION AGREEMENTStock Option Agreement • February 14th, 2017 • Biolargo, Inc. • Chemicals & allied products • Delaware
This Non-Qualified Stock Option Agreement (this “Agreement”) is made and entered into as of February 10, 2017 (the “Grant Date”) by and between BioLargo, Inc., a Delaware corporation (the “Company”), and Charles K. Dargan II, an individual (“Optionee”). Capitalized terms used herein without definition shall have the meanings given to them in Appendix “A” attached hereto and incorporated herein by this reference).
BioLargo, Inc. Engagement Extension AgreementEngagement Extension Agreement • February 14th, 2017 • Biolargo, Inc. • Chemicals & allied products
This Engagement Extension Agreement (the “Extension”) references the Engagement Agreement and Scope Letter dated February 1, 2008 (“2008 Agreement”) by and between CFO 911 (the “Advisor)” and BioLargo, Inc. (the “Company”), and written extensions to the Agreement (the “Prior Extensions”), pursuant to which Charles K. Dargan II has been serving as the Company’s Chief Financial Officer. The parties desire to extend the terms of the prior agreements for a period of one year, pursuant to the terms of this Extension. The 2008 Agreement, the Prior Extensions and this Extension are collectively referred to herein as the “Agreement”.
